Mirae Asset Global ETFs Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.03M Buy
203,494
+26,060
+15% +$132K ﹤0.01% 1432
2025
Q1
$953K Buy
177,434
+12,372
+7% +$66.5K ﹤0.01% 1529
2024
Q4
$1.12M Buy
165,062
+7,939
+5% +$53.7K ﹤0.01% 1490
2024
Q3
$1.05M Buy
157,123
+72,182
+85% +$480K ﹤0.01% 1516
2024
Q2
$638K Buy
+84,941
New +$638K ﹤0.01% 1702